At GSK, we are dedicated to advancing vaccine innovation to protect vulnerable populations, particularly older adults, especially those with underlying medical conditions such as asthma, COPD, ...

we are focused on improving outcomes and the lives of people living with all types of asthma and COPD along with less understood refractory chronic cough or rarer conditions like systemic sclerosis ...

GSK's Nucala (mepolizumab ... we are focused on improving outcomes and the lives of people living with all types of asthma and COPD along with less understood refractory chronic cough or rarer ...

Within the next year, KP-723 is expected to enter several Phase I trials in AD and may have applications in other Th2-mediated diseases, including asthma. 1 “To address the significant unmet need for ...

A high-profile team of architects, landscape designers, and consultants has been appointed to progress a masterplan for the redevelopment of the former GSK headquarters at 980 Great West Road, ...

Last month saw a number of alliances forming in a range of therapeutic spaces but there has been one serial collaborator that stands out – GSK. The British pharma giant seems to have embarked on a ...